This Robert H. Allen, MD, Memorial Hematology Symposia presentation by Enkhtsetseg Purev, MD, PhD, will discuss approaches to harnessing T-cell activity for the treatment of patients with NHL, with a focus on the anti-CD20/CD3 bispecific antibodies mosunetuzumab and glofitamab.
PLEASE NOTE THAT CE CREDIT WILL NOT BE OFFERED FOR THIS PRESENTATION.
Questions may be submitted using the Q/A feature in Zoom during the Q&A portion of the presentation. Due to time limitations, not all submitted questions will be addressed.
To claim CE credit, attendees should complete the appropriate evaluation provided via links in the chat at the end of each presentation.
Recordings of this presentation will be made available to attendees.
We look forward to seeing you there!